Insider Grant: Leisure Lawrence B. Added 2,000 RSUs at P3 Health (PIII)

Rhea-AI Filing Summary

P3 Health Partners Inc. (PIII) Form 4 summary: Director Leisure Lawrence B. was granted 2,000 restricted stock units (RSUs) on 08/06/2025 under the P3 Health Partners 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock and the RSUs vest one year from the grant date. The grant was recorded at a $0 price. Following the reported transaction, the reporting person beneficially owned 218,561 Class A shares. The Form 4 lists the reporting person as a director and was signed by an attorney-in-fact on 08/08/2025.

Insights

Financial Analyst

TL;DR: Routine equity award—small incremental dilution and no cash consideration; limited near-term market impact.

The filing documents a 2,000-RSU grant to Director Leisure Lawrence B. on 08/06/2025 under the 2021 Incentive Award Plan. Each RSU converts to one Class A share and vests in one year. The award was granted at $0, and post-grant beneficial ownership is reported as 218,561 shares. From a capital structure perspective, a 2,000-RSU grant is immaterial relative to the reported holding and is unlikely to move market valuation or materially change share count in the near term.

Corporate Governance Expert

TL;DR: Standard executive compensation action with a one-year vest; disclosure is complete and routine.

The transaction is described as a grant of RSUs pursuant to the company’s 2021 Incentive Award Plan with a one-year vesting schedule, which aligns with common short-term retention practices. The Form 4 identifies the reporting person as a director and provides required details including grant date, amount, post-grant ownership, and an attorney-in-fact signature dated 08/08/2025. The disclosure meets standard Section 16 reporting elements and shows no unusual terms disclosed in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leisure Lawrence B.

(Last) (First) (Middle)

C/O P3 HEALTH PARTNERS INC.

2370 CORPORATE CIRCLE, SUITE 300

(Street)

HENDERSON NV 89074

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
P3 Health Partners Inc. [ PIII ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/06/2025		A		2,000(1)	A	$0	218,561	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock. The RSUs vest in one year from date of grant.

Remarks:

	/s/Todd Smith, Chief Legal Officer, as attorney-in-fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed by P3 Health Partners (PIII) report?

The Form 4 reports a grant of 2,000 RSUs to Director Leisure Lawrence B. on 08/06/2025, awarded under the 2021 Incentive Award Plan.

What do the RSUs represent and when do they vest?

Each RSU represents a right to receive one share of Class A common stock and the RSUs vest one year from the grant date.

Was there any cash paid for the RSUs?

No cash consideration was reported; the grant is recorded at a $0 price in the filing.

How many shares does the reporting person own after the grant?

The filing shows the reporting person beneficially owned 218,561 Class A shares following the reported transaction.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Todd Smith, Chief Legal Officer, as attorney-in-fact on 08/08/2025.